Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 21 (RPSAP21) is one of several processed pseudogenes related to the *RPSA* gene, which encodes the functional ribosomal protein SA (also known as the 37/67 kDa laminin receptor). The functional RPSA protein has important roles in ribosome assembly, cell surface receptor activity, and disease processes like cancer and infection[3][5]. However, RPSAP21 is not a functional protein-coding gene: as a processed pseudogene, it is a non-functional remnant of gene duplication/retrotransposition events and does not encode an active protein or serve as a drug target[5]. Pseudogenes like RPSAP21 may occasionally be transcribed as non-coding RNA but generally lack protein-coding capacity and do not have biological activity comparable to their parent gene[5]. The *RPSA* gene (not its pseudogenes) is sometimes referred to as the laminin receptor and participates in cell adhesion, cancer metastasis, and pathogen entry[3][5]. The functional RPSA gene has a single full-length, protein-coding gene in most species, with multiple pseudogenes of variable sequence and no known direct disease associations or therapeutically relevant function for any pseudogene[5]. There is no evidence linking "RPSAP21" to druggability, biomarkers, or safety concerns in therapeutic development. "RPSAP21" is not a functional molecular target or therapeutic receptor. This entry is best classified as a pseudogene (Other), with no established biological, therapeutic, or diagnostic role. Any information about druggability or disease association applies to the functional parent gene, *RPSA*, and not to this pseudogene[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 21 (RPSAP21).